rs1056433471
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006817.4(ERP29):c.388G>C(p.Val130Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006817.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERP29 | NM_006817.4 | c.388G>C | p.Val130Leu | missense_variant | Exon 3 of 3 | ENST00000261735.4 | NP_006808.1 | |
ERP29 | NM_001034025.2 | c.*87G>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_001029197.1 | |||
LOC124903021 | XR_007063464.1 | n.-104C>G | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERP29 | ENST00000261735.4 | c.388G>C | p.Val130Leu | missense_variant | Exon 3 of 3 | 1 | NM_006817.4 | ENSP00000261735.3 | ||
ERP29 | ENST00000546477.1 | c.85G>C | p.Val29Leu | missense_variant | Exon 3 of 3 | 3 | ENSP00000449018.1 | |||
ERP29 | ENST00000455836.1 | c.*87G>C | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000412083.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.388G>C (p.V130L) alteration is located in exon 3 (coding exon 3) of the ERP29 gene. This alteration results from a G to C substitution at nucleotide position 388, causing the valine (V) at amino acid position 130 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at